The p73 gene is not mutated in oligodendrogliomas which frequently have a deleted region at chromosome 1p36.3

Anticancer Research

Volumn 20, Issue 4, 2000, Pages 2495-2497

  Tsujimoto, Takashi ^a,d   Mochizuchi, Shigenobu ^a   Iwadate, Yasuo ^e   Namba, Hiroki ^f   Nagai, Mariko ^b   Kawamoto, Takemasa ^b   Sunahara, Masao ^b   Yamaura, Akira ^e   Nakagawara, Akira ^b   Sakiyama, Shigeru ^c   Tagawa, Masatoshi ^a,c  

^a Division of Pathology   (Japan)

^b Division of Biochemistry   (Japan)

^c CHIBA CANCER CENTER   (Japan)

^d TOHO UNIVERSITY   (Japan)

^e CHIBA UNIVERSITY   (Japan)

^f HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

1p36; Oligodendroglioma; p73

Indexed keywords

PROTEIN P73;

ARTICLE; CHROMOSOME 1P; CHROMOSOME DELETION; CLINICAL ARTICLE; HUMAN; OLIGODENDROGLIOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HUMANS; MUTATION; NUCLEAR PROTEINS; OLIGODENDROGLIOMA; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEINS;

EID: 0033855692     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Weber RG, Sabel M, Reifenberger J, Sommer C, Oberstrass J, Reifenberger G, Kiessling M and Cremer T: Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. Oncogene 13: 983-994, 1996.
2. Lang FF, Miller DC, Koslow M and Newcomb EW: Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg 81: 427-436, 1994.
3. Iwadate Y, Tagawa M, Fujimoto S, Hirose M, Namba H, Sueyoshi K, Sakiyama S and Yamaura A: Mutation of the p53 gene in human astrocytic tumours correlates with increased resistance to DNA-damaging agents but not to anti-microtubule anti-cancer agents. Br J Cancer 77: 547-551, 1998.
4. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W and Collins VP: Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 145: 1175-1190, 1994,
5. Bello MJ, Vaquero J, De Campos JM, Kusak ME, Sarasa JL, Saez-Castresana J, Pestana A and Key JA: Molecular analysis of chromosome 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumors. Int J Cancer 57: 172-175, 1994.
6. Smith JS, Alderete B, Minn Y, Borell TJ, Perry A et al: Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene 18: 4144-4152, 1999.
7. Rosso SM, van Dekken H, Krishnadath KK, Alers JC and Kros JM: Detection of chromosomal changes by interphase cytogenetics in biopsies of recurrent astrocytomas and oligodendrogliomas. J Neuropathol Exp Neurol 56: 1125-1131, 1997.
8. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan J-C, Valent A, Minty A, Chalon P, Lelias J-M, Dumont X, Ferrara P, McKeon F, Caput D: Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90: 809-819, 1997.
9. Kaelin WGJr: The p53 gene family. Oncogene 18: 7701-7705.
10. Jost CA, Marin MC and Kaelin WGJr: p73 is a human p53-related protein that can induce apoptosis. Nature 389: 191-194, 1997.
11. Nomoto S, Haruki N, Kondo M, Konishi H, Takahashi T, Takahashi T and Takahashi T. Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancer. Cancer Res 58: 1380-1383, 1998.
12. Nimura Y, Mihara M, Ichimiya S, Sakiyama S, Seki N, Ohira M, Nomura N, Fujimori M, Adachi W, Amano J, He M, Ping Y-M and Nakagawara A: p73, a gene related to p53, is not mutated in esophageal carcinomas. Int J Cancer 78: 437-440, 1998.
13. Sunahara M, Ichimiya S, Nimura Y, Takada N, Sakiyama S, Sato Y, Todo S, Adachi W, Amano J and Nakagawara A: Mutational analysis of the p73 gene localized at chromosome 1p36.3 in colorectal carcinomas. Int J Oncol 13: 319-323, 1998.
14. Tsao H, Zhang X, Majewski P and Haluska FG: Mutational and expression analysis of the p73 gene in melanoma cell lines. Cancer. Res 59: 172-174, 1999.
15. Kleihues P, Burger PC and Scheithauer BW: Histological typing of tumours of the central nervous system, Berlin, Springer-Verlag, 1993.
16. Mai M, Huang H, Reed C, Qian C, Smith JS, Alderete B, Jenkins R, Smith DI and Liu W: Genomic organization and mutation analysis of p73 in oligodendrogliomas with chromosome 1p-arm deletions. Genomics 51: 359-363, 1998.
17. Ichimiya S, Nimura Y, Kageyama H, Takada N, Sunahara M, Shishikura T, Nakamura Y, Sakiyama S, Seki N, Ohira M, Kaneko Y, McKeon F, Caput D and Nakagawara A: p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent. Oncogene 18: 1061-1066, 1999.
18. Mai M, Qian C, Yokomizo A, Tindall DJ, Bostwick D, Polychronakos C, Smith DI and Liu W: Loss of imprinting and allele switching of p73 in renal cell carcinoma. Oncogene 17: 1739-1741, 1998.
19. Zhu J, Jiang J, Zhou W and Chen X; The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res 58: 5061-5065, 1998.
20. Husemann K, Welter M, Buschges R, Bostrom J, Sabel M and Reifenberger G: Identification of two distinct deleted regions on the short arm of chromosome 1 and rare mutation of the CDKN2C gene from 1p32 in oligodendroglial tumors. J Neuropathol Exp Neurol 58: 1041-1050, 1999.